Affordable Access

deepdyve-link
Publisher Website

Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]

Authors
  • Mohammed El Tabaa, Manar1
  • Mohammed El Tabaa, Maram2
  • 1 Pharmacology & Environmental Toxicology, Environmental Studies & Research Institute, University of Sadat City, Egypt
  • 2 Medical Physiology, Faculty of Medicine, Tanta University, Egypt
Type
Published Article
Journal
Biochemical pharmacology
Publisher
New York, NY : Elsevier Science Inc
Publication Date
Oct 04, 2020
Volume
182
Pages
114249–114249
Identifiers
DOI: 10.1016/j.bcp.2020.114249
PMID: 33027739
PMCID: PMC7533109
Source
PubMed Central
Disciplines
  • Corrigendum
License
Unknown
Report this publication

Statistics

Seen <100 times